Features
Business
FSD Pharma receives cannabis sales license from Health Canada
Pharmaceutical company FSD Pharma announced that its wholly-owned subsidiary, Cobourg, Ont.-based licenced cannabis producer FV Pharma Inc. has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act. The license went into effect on April 18, 2019.
April 29, 2019 By Grow Opportunity Staff
The license allows the current FSD facility to supply and sell cannabis products. The company said it anticipates receiving the amended sales license that will include the sale of dried and fresh cannabis flower in the near future.
“Our sales license is a key development for FSD Pharma and a huge success and step forward for our Cobourg facility,” said Dr. Raza Bokhari, executive co-chairman and chief executive of FSD Pharma.
FSD Pharma is focused on the development of indoor grown, pharmaceutical grade cannabis and on the research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome. The company has 25,000 square feet available for production at its Ontario facility.
“We have achieved this milestone thanks to the efforts of our dedicated team. We are exceptionally proud of this achievement and look forward to accelerating our efforts,” said Dr. Sara May, president of FV Pharma Inc.
“The granting of our sales license allows FSD to serve the growing medicinal use markets in Canada. We intend to quickly scale up production at our current facility, while continuing to build out the plant to add additional grow capacity,” added president and founder Zeeshan Saeed.
FV Pharma said it’s working to transform its current headquarters in a Kraft plant in Cobourg into the largest hydroponic indoor grow facility in the world.
Print this page
